Showing results (131-140 of 182) with videos related to

Sort By:
Pageof 19
Circulation. Cardiovascular Interventions|January 10, 2018
Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-AnalysisSammy Elmariah, Gheorghe Doros, Oscar R Benavente, et al.
American Journal of Translational Research|May 18, 2016
Privacy and security in the era of digital health: what should translational researchers know and do about it?Barbara L Filkins, Ju Young Kim, Bruce Roberts, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|October 2, 2012
Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation modelJoseph D Foley, J Darrell Sneed, Steven R Steinhubl, et al.
JAMA|July 13, 2018
Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical TrialSteven R Steinhubl, Jill Waalen, Alison M Edwards, et al.
The Lancet. Digital Health|September 26, 2022
Sensor-based surveillance for digitising real-time COVID-19 tracking in the USA (DETECT): a multivariable, population-based, modelling studyJennifer M Radin, Giorgio Quer, Jay A Pandit, et al.
Archives of Cardiovascular Diseases|August 12, 2009
Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trialJean-Philippe Collet, Gilles Montalescot, Philippe Gabriel Steg, et al.
American Heart Journal|July 12, 2011
Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialJeffrey S Berger, Deepak L Bhatt, P Gabriel Steg, et al.
American Heart Journal|March 30, 2002
The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapyGuy L Wheeler, Gregory A Braden, Steven R Steinhubl, et al.
Circulation|June 3, 2010
Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialPeter B Berger, Deepak L Bhatt, Valentin Fuster, et al.
Circulation|November 26, 2009
Smoking, clopidogrel, and mortality in patients with established cardiovascular diseaseJeffrey S Berger, Deepak L Bhatt, Steven R Steinhubl, et al.
Pageof 19